亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

維生素A醋酸酯 CAS:127-47-9

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過期 長(zhǎng)期有效
更新 2021-11-25 12:21
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會(huì)員第5年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

nkl-00136
中文名稱:維生素A醋酸酯
中文別名:維生素A乙酸酯
英文名稱:Retinyl acetate
英文別名: Retinol, acetate, all-trans- (8CI); Arovit; Myvak; Myvax; NSC 122045; NSC 122760; Retinol acetate; Retinyl acetate; Ro 1-5275;Rovimix A 1000; Vitamin A acetate; all-trans-Retinyl acetate; all-trans-Vitamin A acetate; trans-Retinol acetate; trans-Retinyl acetate;Vitamin A1 acetate; all-trans-Retinol acetate
CAS號(hào):127-47-9

純度: HPLC≥98%

分子式:C22H32O2
分子量:328.49
產(chǎn)品外觀:流動(dòng)性好的淺黃色精細(xì)球型狀顆粒粉末,無異味
熔點(diǎn): 57-58 °C
沸點(diǎn): 440.5±14.0 °C | Condition
密度: 0.968±0.06 g/cm3 | Condition: Temp: 20 °C
溶解性:溶于水
藥理藥效:能透皮吸收,抗角質(zhì)化,刺激膠原蛋白和彈性蛋白的生長(zhǎng),增加表皮及真皮的厚度。增強(qiáng)皮膚彈性,有效消除皺紋,促進(jìn)皮膚更新,保持皮膚活力。用于眼霜、保濕霜、修護(hù)霜、香波、護(hù)發(fā)素
規(guī)格:10mg,20mg,50mg;可根據(jù)客戶需求包裝、定制

儲(chǔ)存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測(cè)定、藥理實(shí)驗(yàn)、活性篩選等科研、實(shí)驗(yàn)室使用;不得直接用于人體

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
2”-O-沒食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |